Table 2.
Steps and intensity of habitual physical activity over time in the ETI group and the non-ETI group from baseline to follow-up.
| ETI group (n = 21) | non-ETI group (n = 6) | Between-group comparison p-value | Within-group comparison p-value | |||||
|---|---|---|---|---|---|---|---|---|
| Baseline | Follow-up | Baseline | Follow-up | Baseline | Follow-up | ETI group | non-ETI group | |
| Steps (number/day) | 8,798 ± 3,176 (7,352/10,243) | 10,997 ± 3,468 (9,354/12,600)* | 11,530 ± 3,636 (8,490/14,569) | 11,164 ± 3,724 (8,716/14,908) | 0 . 042 | 0.785 | 0.019 | 0.893 |
| Total change (steps/day) | 2,131.3 ± 3,268.7 (556.4/3,707.3) | −305.7 ± 2,628.1 (−2,351.7, 1,740.3) | ||||||
| Annual change in steps/day | 414.0 ± 699.5 (76.9/751.2) | −86.8 ± 401.0 (457.6/284.1) | 0.060 | |||||
| Sedentary-to-light intensity HPA (<3 METs), in min/day | 1,218.5 ± 133.9 (1,149.6/1,287.4) | 1,170.6 ± 117.6 (1,115.7/1,287.4) | 1,254.1 ± 197.4 (763.8/1,744.4) | 1,103.0 ± 136.8 (885.4/1,320.6) | 0.491 | 0.278 | 0.543 | 0.416 |
| Moderate-to-vigorous intensity HPA (3–5.9 METs), in min/day | 106.3 ± 90.6 (60.2/140.3) | 112.1 ± 74.1 (74.4/143.8) | 123.0 ± 101.0 (17.0/229.0) | 92.2 ± 36.8 (46.5/137.9) | 0.466 | 0.946 | 0.352 | 0.207 |
| Vigorous HPA (≥6 METs), in min/day | 16.7 ± 18.7 (6.5/27.7) | 13.6 ± 18.6 (8.2, 22.3) | 19.6 ± 20.0 (2.9/36.4) | 18.3 ± 18.3 (−0.9/7.6) | 0.767 | 0.407 | 0.363 | 0.465 |
Values are mean ± standard deviation (95% confidence interval).
Baseline, assessment of habitual physical activity and clinical parameters; Follow-up, assessment of habitual physical activity and clinical parameters. Statistical testing: Kruskal–Wallis test (between groups); Mann–Whitney U-test (within groups); Friedman two-way analysis of variance by ranks test to compare the changes over time; Chi-Quadrat (2), χ² (post hoc tests).
HPA, habitual physical activity; ETI, elexacaftor/tezacaftor/ivacaftor; METS, metabolic equivalents.
Bold type indicates a significant result.